Cargando…
Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era
The research on the anti-SARS-CoV-2 vaccines and their commercialization is an opportunity to test and consolidate the current knowledge along with the diverse available tools related to vaccine communication. In this paper we explore the value of a multidisciplinary approach in this field: vaccine...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920147/ https://www.ncbi.nlm.nih.gov/pubmed/33764272 http://dx.doi.org/10.1080/21645515.2020.1865048 |
_version_ | 1784669064214347776 |
---|---|
author | Gesualdo, Francesco Bucci, Lucie M. Rizzo, Caterina Tozzi, Alberto E. |
author_facet | Gesualdo, Francesco Bucci, Lucie M. Rizzo, Caterina Tozzi, Alberto E. |
author_sort | Gesualdo, Francesco |
collection | PubMed |
description | The research on the anti-SARS-CoV-2 vaccines and their commercialization is an opportunity to test and consolidate the current knowledge along with the diverse available tools related to vaccine communication. In this paper we explore the value of a multidisciplinary approach in this field: vaccine communication activities can be combined with insights from data science, risk communication, behavior change, design thinking and digital marketing. Methodologies derived from innovation and human-centered design can contribute to the development and testing of vaccine promotion campaigns, speeding up processes and streamlining the production of evidence in this area. The multiple activities involving the anti-SARS-CoV-2 vaccine could be the fertile ground in which to develop, test and refine effective frameworks to transfer data acquired through listening strategies into effective vaccine promotion campaigns. The World Health Organization’s Vaccine Safety Net is an interesting example of trusted information sources that aim toward using digital tools and innovative methodologies for communicating science-based information on vaccine safety at the global level. |
format | Online Article Text |
id | pubmed-8920147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89201472022-03-15 Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era Gesualdo, Francesco Bucci, Lucie M. Rizzo, Caterina Tozzi, Alberto E. Hum Vaccin Immunother Coronavirus – Commentary The research on the anti-SARS-CoV-2 vaccines and their commercialization is an opportunity to test and consolidate the current knowledge along with the diverse available tools related to vaccine communication. In this paper we explore the value of a multidisciplinary approach in this field: vaccine communication activities can be combined with insights from data science, risk communication, behavior change, design thinking and digital marketing. Methodologies derived from innovation and human-centered design can contribute to the development and testing of vaccine promotion campaigns, speeding up processes and streamlining the production of evidence in this area. The multiple activities involving the anti-SARS-CoV-2 vaccine could be the fertile ground in which to develop, test and refine effective frameworks to transfer data acquired through listening strategies into effective vaccine promotion campaigns. The World Health Organization’s Vaccine Safety Net is an interesting example of trusted information sources that aim toward using digital tools and innovative methodologies for communicating science-based information on vaccine safety at the global level. Taylor & Francis 2021-03-25 /pmc/articles/PMC8920147/ /pubmed/33764272 http://dx.doi.org/10.1080/21645515.2020.1865048 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Coronavirus – Commentary Gesualdo, Francesco Bucci, Lucie M. Rizzo, Caterina Tozzi, Alberto E. Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title | Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title_full | Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title_fullStr | Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title_full_unstemmed | Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title_short | Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era |
title_sort | digital tools, multidisciplinarity and innovation for communicating vaccine safety in the covid-19 era |
topic | Coronavirus – Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920147/ https://www.ncbi.nlm.nih.gov/pubmed/33764272 http://dx.doi.org/10.1080/21645515.2020.1865048 |
work_keys_str_mv | AT gesualdofrancesco digitaltoolsmultidisciplinarityandinnovationforcommunicatingvaccinesafetyinthecovid19era AT bucciluciem digitaltoolsmultidisciplinarityandinnovationforcommunicatingvaccinesafetyinthecovid19era AT rizzocaterina digitaltoolsmultidisciplinarityandinnovationforcommunicatingvaccinesafetyinthecovid19era AT tozzialbertoe digitaltoolsmultidisciplinarityandinnovationforcommunicatingvaccinesafetyinthecovid19era |